|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
2/2013
vol. 115 abstract:
Review paper
Mucopolysaccharidosis and organ of sight
Monika Modrzejewska
1
,
Joanna Kot
1
,
Agnieszka Wiśniewska
2
,
Hanna Romanowska
2
,
Maria Giżewska
2
Klinika Oczna 2013, 115 (2): 152-157
Online publish date: 2013/06/21
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Mucopolysaccharidoses are a group of genetically determined storage diseases in which lysosomal enzyme deficiency leads to a vast accumulation of glycosaminoglycans in tissues. Depending on the sort of deficient enzyme MPS are divided into the types marked with Roman numerals. Clinical symptoms are caused by the involvement of the nervous, respiratory, visceral and skeletal system, organ of hearing and sight. Ocular manifestations result in significant visual impairment. Ophthalmic symptoms include corneal opacification, glaucoma, optic nerve swelling and retinopathy. Modern methods for the treatment involving enzyme replacement therapy and bone marrow transplantation significantly improved the prognosis in many cases. This article presents a brief description of mucopolysaccharidoses, concentrating mainly on ocular symptoms and their possible treatments.
keywords:
mucopolysaccharidosis, organ of vision, clinical symptoms, treatment |
|
POLSKI
